Similar articles

• Aliskiren combined with losartan in diabetes and nephropathy.

  Anderson S, Komers R. Anderson S, et al. N Engl J Med. 2008 Sep 4;359(10):1069; author reply 1069-70. N Engl J Med. 2008. PMID: 18777613 No abstract available.
• Aliskiren and dual therapy in type 2 diabetes mellitus.

  Ingelfinger JR. Ingelfinger JR. N Engl J Med. 2008 Jun 5;358(23):2503-5. doi: 10.1056/NEJMe0803375. N Engl J Med. 2008. PMID: 18525047 No abstract available.
• Aliskiren combined with losartan in diabetes and nephropathy.

  Panesar M, Damodar A. Panesar M, et al. N Engl J Med. 2008 Sep 4;359(10):1068; author reply 1069-70. doi: 10.1056/NEJMc081393. N Engl J Med. 2008. PMID: 18768954 No abstract available.
• Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?

  Gaddam KK, Oparil S. Gaddam KK, et al. Curr Opin Nephrol Hypertens. 2008 Sep;17(5):484-90. doi: 10.1097/MNH.0b013e32830baa9b. Curr Opin Nephrol Hypertens. 2008. PMID: 18695389 Review.
• Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?

  Pimenta E, Oparil S. Pimenta E, et al. Cardiol Clin. 2008 Nov;26(4):527-35. doi: 10.1016/j.ccl.2008.06.003. Cardiol Clin. 2008. PMID: 18929229 Review.